Wang, K., Xing, Z., Jiang, Q., Yang, Y., Huang, J., Yuan, M., . . . Shi, Z. (2019). Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance. Front Oncol.
シカゴスタイル引用形Wang, Kun, et al. "Targeting UPAR By CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance." Front Oncol 2019.
MLA引用形式Wang, Kun, et al. "Targeting UPAR By CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance." Front Oncol 2019.
警告: この引用は必ずしも正確ではありません.